You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

39 Results
Guidelines and Advice
Status: Current
ID: PET 2015-1
Oct 2015
Guidelines and Advice
Status: Current
ID: SCT-7
Sep 2015
Guidelines and Advice
Status: Current
ID: PET 2014-2
Jun 2015
Guidelines and Advice
Status: Current
ID: PET 12
Mar 2015
Guidelines and Advice
Status: Current
ID: 12-11
Version: 2
Apr 2023
Cancer facts
May 2015
Guidelines and Advice
Status: Current
ID: GL-C50-20
May 2015
Drug
Other Name(s): Alimta®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2023
Drug
Other Name(s): Pomalyst®
Quick Link(s): Drug Monograph, Patient Info Sheet
Aug 2023
Drug
Other Name(s): Iclusig®
Quick Link(s): Drug Monograph, Patient Info Sheet
Aug 2023
Regimen
Cancer Type:
Central Nervous System
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Curative, Palliative
Funding:
ODB - General Benefit
    procarbazine
ODB - General Benefit
    lomustine
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
lomustine,
procarbazine,
vinCRIStine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jan 2023
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Panitumumab - Metastatic Colorectal Small Bowel or Appendiceal Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
PANitumumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2023

Pages